Samuel Levy

620 total citations
16 papers, 181 citations indexed

About

Samuel Levy is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Samuel Levy has authored 16 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Samuel Levy's work include Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Samuel Levy is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Samuel Levy collaborates with scholars based in United States, Canada and United Kingdom. Samuel Levy's co-authors include Aaron Scott, Gulfem D. Guler, Yuhong Ning, Tierney Phillips, Anna Bergamaschi, Stephen R. Quake, Erin McCarthy, François Collin, Chin‐Jen Ku and Alan Ashworth and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Samuel Levy

14 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Levy United States 5 95 84 68 22 21 16 181
Iddrisu Baba Yabasin Ghana 9 118 1.2× 78 0.9× 32 0.5× 32 1.5× 15 0.7× 19 212
Matthew Lane United States 6 32 0.3× 22 0.3× 25 0.4× 39 1.8× 29 1.4× 8 155
Dorota J. Hawksworth United States 6 97 1.0× 45 0.5× 26 0.4× 35 1.6× 76 3.6× 13 232
Sylvia Hartmann Germany 6 60 0.6× 16 0.2× 33 0.5× 4 0.2× 10 0.5× 17 126
Jed Kaminetsky United States 7 61 0.6× 67 0.8× 18 0.3× 17 0.8× 104 5.0× 10 204
O Alobeed Saudi Arabia 4 68 0.7× 57 0.7× 77 1.1× 4 0.2× 34 1.6× 8 168
Marla Lipsyc-Sharf United States 7 54 0.6× 108 1.3× 122 1.8× 3 0.1× 60 2.9× 24 225
Elnaz Naderi Netherlands 7 21 0.2× 24 0.3× 20 0.3× 6 0.3× 12 0.6× 14 97
Laimin Luo China 7 36 0.4× 16 0.2× 18 0.3× 3 0.1× 17 0.8× 17 124
Bibek Das United Kingdom 6 38 0.4× 45 0.5× 56 0.8× 3 0.1× 22 1.0× 21 170

Countries citing papers authored by Samuel Levy

Since Specialization
Citations

This map shows the geographic impact of Samuel Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Levy more than expected).

Fields of papers citing papers by Samuel Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Levy. The network helps show where Samuel Levy may publish in the future.

Co-authorship network of co-authors of Samuel Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Levy. A scholar is included among the top collaborators of Samuel Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Levy. Samuel Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kelly, John F., et al.. (2024). A systematic qualitative study investigating why individuals attend, and what they like, dislike, and find most helpful about, smart recovery, alcoholics anonymous, both, or neither. Journal of Substance Use and Addiction Treatment. 161. 209337–209337. 4 indexed citations
3.
Xue, Yuan, Glenn Oliveira, Verena Friedl, et al.. (2024). Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Signatures. Journal of Molecular Diagnostics. 26(10). 888–896. 4 indexed citations
4.
Guler, Gulfem D., Yuhong Ning, Ceyda Çoruh, et al.. (2024). Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 12(1). e008028–e008028. 10 indexed citations
5.
Kelly, John F., Samuel Levy, & Bettina B. Hoeppner. (2023). An investigation of SMART Recovery: protocol for a longitudinal cohort study of individuals making a new recovery attempt from alcohol use disorder. BMJ Open. 13(2). e066898–e066898. 1 indexed citations
6.
Kelly, John F., et al.. (2023). Who affiliates with SMART recovery? A comparison of individuals attending SMART recovery, alcoholics anonymous, both, or neither. Alcohol Clinical and Experimental Research. 47(10). 1926–1942. 5 indexed citations
7.
Bergamaschi, Anna, et al.. (2023). Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA.. Journal of Clinical Oncology. 41(4_suppl). 672–672. 2 indexed citations
8.
Haan, David, Gulfem D. Guler, Anna Bergamaschi, Wayne Volkmuth, & Samuel Levy. (2022). Pancreatic cancer detection using 5-hydroxymethylation signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes.. Journal of Clinical Oncology. 40(4_suppl). 539–539. 2 indexed citations
9.
Haan, David, Anna Bergamaschi, Yuhong Ning, et al.. (2021). Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.. Journal of Clinical Oncology. 39(15_suppl). 3044–3044. 1 indexed citations
10.
Guler, Gulfem D., Anna Bergamaschi, David Haan, et al.. (2021). Pancreatic cancer detection using EpiDetect signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes.. Journal of Clinical Oncology. 39(15_suppl). e16265–e16265.
11.
Sjöström, Martin, Shuang G. Zhao, Eric J. Small, et al.. (2021). 5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC.. Journal of Clinical Oncology. 39(6_suppl). 148–148. 3 indexed citations
12.
Guler, Gulfem D., Yuhong Ning, Chin‐Jen Ku, et al.. (2020). Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nature Communications. 11(1). 5270–5270. 119 indexed citations
13.
Collin, François, Yuhong Ning, Gulfem D. Guler, et al.. (2019). Abstract 1372: Detection of early stage pancreatic cancer using 5–hydroxymethylcytosine signatures in circulating cell free DNA. Cancer Research. 79(13_Supplement). 1372–1372. 1 indexed citations
14.
Collin, François, Yuhong Ning, Gulfem D. Guler, et al.. (2019). Abstract 1372: Detection of early stage pancreatic cancer using 5–hydroxymethylcytosine signatures in circulating cell free DNA. 1372–1372. 1 indexed citations
15.
Levy, Samuel, et al.. (2008). Ankylosing spondylitis and pulmonary sarcoidosis--a case report and discussion of the literature. Lara D. Veeken. 47(11). 1733–1734. 5 indexed citations
16.
Gratz, Irwin, et al.. (1994). Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia.. PubMed. 10(3). 212–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iddrisu Baba Yabasin Breakdown of academic impact, for papers by Matthew Lane Breakdown of academic impact, for papers by Dorota J. Hawksworth Breakdown of academic impact, for papers by Sylvia Hartmann Breakdown of academic impact, for papers by Jed Kaminetsky Breakdown of academic impact, for papers by O Alobeed Breakdown of academic impact, for papers by Marla Lipsyc-Sharf Breakdown of academic impact, for papers by Elnaz Naderi Breakdown of academic impact, for papers by Laimin Luo Breakdown of academic impact, for papers by Bibek Das
Rankless by CCL
2026